Jan Van Acker

Global Biopharma and Healthcare Executive | Senior Advisor | Board Member

Lucerne, Lucerne, Switzerland

About

I am passionate about making a difference. What energizes me every day is to work with great people, coaching and guiding leaders to constantly innovate and learn and grow, and achieve significant impact and success at scale even in the face of high complexity and uncertainty ... ... and to apply "big-dream" thinking and radical innovation to drive broad access and tackle important healthcare challenges.

Experience

  • Non-Executive Board Member at Kolon TissueGene, Inc.
    Mar 2026 - Present Β· 5 mos

  • Chief Strategy Officer - ARC Global at dGA
    Jan 2025 - Present Β· 1 yr 7 mos

    𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐒𝐨𝐧 𝐭𝐨 𝐝𝐫𝐒𝐯𝐞 𝐑𝐞𝐚π₯𝐭𝐑𝐜𝐚𝐫𝐞 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐒𝐨𝐧. β€’ ARC is unique globally as an in-house hospital innovation model focused on building startups which address the biggest challenges to achieve healthcare transformation; β€’ First started at Sheba Medical Center, now with 130 startups valued at $7B end of 2025; β€’ Supporting to build the model Charite (Berlin), UCLP (London), SingHealth (Singapore), Albert Einstein (Brazil), Cedars Sinai (LA); β€’ Advising the CEO/Founder in building ARC Global, a startup platform company managing a unique federated global network of innovation hubs across top hospitals

  • Impact focused on broad access in LMIC, under MIT JPAL at Pro-bono Advisor
    Feb 2025 - Present Β· 1 yr 6 mos

    𝐈𝐦𝐩𝐚𝐜𝐭 𝐒𝐧 𝐚𝐜𝐜𝐞𝐬𝐬, 𝐚𝐭 𝐬𝐜𝐚π₯𝐞. β€’ Building a β€œscience of medicines access” center of excellence under the MIT Jameel Poverty Action Lab using JPAL's methodology β€’ Vision is to develop a broad repository of practical and innovative actions that biopharma companies and relevant NGOs can tap in to exponentially accelerate access to new medicines and create a triple win: for patients, for healthcare providers and systems, and for biopharma companies

  • Strategic Advisor to Healthtech startups at Shela Health / Cascador
    Nov 2024 - Present Β· 1 yr 9 mos

  • Strategic Advisor to biotech startups at Starget Pharma
    Dec 2024 - Present Β· 1 yr 8 mos